Genova, C., Marconi, S., Croce, M., Santamaria, S., Rosa, A., Rossi, G., . . . Coco, S. (2023, November). Circulating PD-L1 and TIM3 as Prognostic Markers in Patients With Advanced Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor. The Journal of Liquid Biopsy.
Chicago Style (17th ed.) CitationGenova, C., et al. "Circulating PD-L1 and TIM3 as Prognostic Markers in Patients With Advanced Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor." The Journal of Liquid Biopsy Nov. 2023.
MLA (9th ed.) CitationGenova, C., et al. "Circulating PD-L1 and TIM3 as Prognostic Markers in Patients With Advanced Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor." The Journal of Liquid Biopsy, Nov. 2023.
Warning: These citations may not always be 100% accurate.